Search Results 51-60 of 16569 for Cirrhosis
Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Risk ...
Maintain a healthy weight. Obesity can cause a condition called nonalcoholic fatty liver disease, which may include fatty liver, hepatitis and cirrhosis. The ...
Research. Mayo Clinic researchers are committed to improving diagnosis and treatment of cirrhosis of the liver. Mayo researchers were among the first to ...
But untreated liver fibrosis may progress to cirrhosis, which is advanced fibrosis and scarring. Cirrhosis can be fatal. If diagnosed, liver fibrosis often ...
The purpose of this study is to find out how the survival rate of patients with cirrhosis can be improved when admitted to the hospital with complications such ...
Resmetirom (Rezdiffra) can help reduce the amount of fat that collects in the liver. This medicine is not recommended for people with cirrhosis. For those who ...
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) · Overview.
This Registry will enroll cirrhotic participants with or without decompensated liver disease who have achieved a sustained virologic response (SVR) after ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.